0Rolling out
0Pilots
0Pulled back
1Plans and forecasts
1Jobs affected
Aug 2026First tracked
What does this mean for workers? Vitestro's move touches 1 job, which employs about 144,000 people in the U.S. For phlebotomists, AI and robots already touch about 2h 47m of a typical 8-hour shift. A single company's move is an early signal for these jobs, and the time cards show how far the change has spread nationally.
Announced means the company said it would do this; nothing is running yet.
On the floor
- FDA authorizes Vitestro's Aletta robot to draw blood on its own
The FDA authorized Aletta on August 19, 2026 for adults in outpatient settings, with one trained phlebotomist overseeing up to three devices. In a 1,633-patient study the needle went in on the first try 94.5% of the time.
Jobs affected
HumanWith AIAIRobot